Exploring the differences between socio-economic groups to know their perspective and mind set about generic medicines
Keywords:
exploring, socio-economic, perspective, generic medicinesAbstract
Medicines comprise an important element in healthcare, providing protection, restoring and maintaining people’s wellbeing. Then the availability and excess of appropriate medicines of accrued quality, and quantities at reasonable prices are thus, a concern of global and national policymakers, health agencies and organizations. Pharmaceuticals and medicines form a sizeable outer pocket expenditure of health in Indian households. In the context of providing universal health care, providing financial risk protection to households affected by illness is a key objective with a focus on providing cover for medicines. To address this issue, the Government of India launched the Jan Aushadhi (Medicine for the Masses) Scheme (JAS) to provide cheap generic medicines to patients. Jan Aushadi stores have been established across the country to supply generic medicines. Generic medicines provide an option for patients to reduce their out-of-pocket expenses, as generic medicines are usually priced 10-80 % less than their branded counterparts. In the last FRGS project[1] researcher wanted to see the prescription of patients from government and private hospitals in southwest Delhi, Dwarka and the compliance with Rule 1.5 of Medical Council Rule 2002.
Downloads
References
Suryasa, I.W., Sudipa, I.N., Puspani, I.A.M., Netra, I.M. (2019). Translation procedure of happy emotion of english into indonesian in kṛṣṇa text. Journal of Language Teaching and Research, 10(4), 738–746
Suryasa, W. (2019). Historical Religion Dynamics: Phenomenon in Bali Island. Journal of Advanced Research in Dynamical and Control Systems, 11(6), 1679-1685.
Dr. Kavita Solanki, “Acquisition of affordable healthcare through generic medicines: An empirical study in Dwarka, Delhi” ILI Law Review, Winter Issue ,224(2020)
IPA (Indian Pharmaceutical Alliance), The Indian Pharmaceutical industry- the way forward, June 2019, p.7- Make in India, IBEF Inidan Pharma Outlook and Brand India.
Ibid
Ibid, Press Information Bureau, “Affordable Efficacious Medicines All Roads Leads to India” 2013 report by IDMA; Brandindia.pharma.in
Gx prescriptions account for 90% prescriptions, Indian Companies account for 40% share of Gx prescription, IQVIA 2019
UK and India regulators agree deal for closer collaboration to improve public safety, press release, Government of UK 5 Oct 2015.
Pharmaceuticals: India’s generics flow into Africa, African Businesses Magazine, 19 January 2012.
Praveen Kumar Aivalli, “Perceptions of the quality of generic medicines:Implication for trust in public,services within the local health systems in Tumkur, India”, BMJ, Global Health (2018), 10
Suryakanta Swain- Indian Pharma Industry: SWOT Analysis; Internet report June, 2009.
Dunne and Dunne “What do people really think of generic medicines? A systematic review and critical appraisal of literature on Stakeholder perceptions of generic drugs, BMC Medicine (2015) 13:173
Ibid, World Health Organisation (WHO). Generic Drugs, Geneva: WHO; 2015. http://www.who.int/trade/glossary/story 034/en/index.html. Accessed 21 June 2015
the European Medicines Agency (EMA) definition is: “A generic medicine is a medicine that is developed to be the same as a medicine that has already been authorized (‘the reference medicine’). Generic medicine contains the same active substance(s) as the reference medicine, and it is used at the same dose(s) to treat the same disease(s) as the reference medicine. However, the name of the medicine, its appearance (such as colour or shape) and its packaging can be different from those of the reference medicine.
An Active ingredient is any component that provides pharmacological activity or other direct effect in the diagnosis, cure, mitigation ,treatment or prevention of disease, or to affect the structure or any function of the body of man or animal .Available at www.fda.gov last visited on 5.5.2020
Ibid Organisation for Economic, Co-operation and Development (OCED) What future for health spending? OCED
Willium H. Shrank, Suzame. M. Cadarette “Is there a relationship between patient’s belief or communications about generic drugs and medication utilization? Walter Kluwer, JSTOR-Medical Care-Vol 47, Number 3, March 2009
Ibid
Ibid pg 226
Ibid pg 228
Swain S, Dey A, Patra CN, Bhanoji Rao ME (2014) ,”Pharma Regulations for Generic Drug Products in India and US: Case Studies and Future Prospectives”. Pharmaceut Reg Affairs SSN: 2167-7689 Volume 3 Issue 2
Ibid
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.








